Jiangsu Yuyue Medical Equipment & Supply Toekomstige groei
Future criteriumcontroles 2/6
Jiangsu Yuyue Medical Equipment & Supply zal naar verwachting groeien in winst en omzet met respectievelijk 18.7% en 16% per jaar. De winst per aandeel zal naar verwachting groeien met 18.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 16% zijn.
Belangrijke informatie
18.7%
Groei van de winst
18.6%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 26.6% |
| Inkomstengroei | 16.0% |
| Toekomstig rendement op eigen vermogen | 16.0% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 05 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Why Jiangsu Yuyue Medical Equipment & Supply's (SZSE:002223) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 03
Here's Why Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Can Manage Its Debt Responsibly
Sep 13Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Has More To Do To Multiply In Value Going Forward
Aug 14Here's Why Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Has Caught The Eye Of Investors
Jul 29Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Is Paying Out A Larger Dividend Than Last Year
May 26Is Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) A Risky Investment?
May 21Jiangsu Yuyue Medical Equipment & Supply's (SZSE:002223) Profits May Not Reveal Underlying Issues
May 03Earnings Report: Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Missed Revenue Estimates By 7.0%
Apr 30The Return Trends At Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Look Promising
Apr 22Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.'s (SZSE:002223) Shares Lagging The Market But So Is The Business
Apr 03Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 10,776 | 2,777 | N/A | 2,773 | 10 |
| 12/31/2025 | 9,422 | 2,386 | N/A | 2,334 | 11 |
| 12/31/2024 | 8,248 | 2,082 | N/A | 1,794 | 11 |
| 9/30/2024 | 7,337 | 1,737 | 1,665 | 1,763 | N/A |
| 6/30/2024 | 7,299 | 2,022 | 1,539 | 1,641 | N/A |
| 3/31/2024 | 7,423 | 2,242 | 1,706 | 1,818 | N/A |
| 12/31/2023 | 7,972 | 2,396 | 1,994 | 2,127 | N/A |
| 9/30/2023 | 8,648 | 2,650 | 2,602 | 2,885 | N/A |
| 6/30/2023 | 8,529 | 2,302 | 2,501 | 2,877 | N/A |
| 3/31/2023 | 7,983 | 1,845 | 2,335 | 2,708 | N/A |
| 1/1/2023 | 7,102 | 1,595 | 1,926 | 2,305 | N/A |
| 9/30/2022 | 6,700 | 1,266 | 1,121 | 1,280 | N/A |
| 6/30/2022 | 6,854 | 1,307 | 1,224 | 1,328 | N/A |
| 3/31/2022 | 7,054 | 1,487 | 1,297 | 1,441 | N/A |
| 1/1/2022 | 6,894 | 1,482 | 917 | 1,201 | N/A |
| 9/30/2021 | 7,188 | 1,600 | 578 | 1,365 | N/A |
| 6/30/2021 | 6,898 | 1,603 | 491 | 1,255 | N/A |
| 3/31/2021 | 6,996 | 1,836 | 1,379 | 2,053 | N/A |
| 12/31/2020 | 6,726 | 1,759 | 2,152 | 2,831 | N/A |
| 9/30/2020 | 5,928 | 1,550 | 2,770 | 3,033 | N/A |
| 6/30/2020 | 5,555 | 1,339 | 2,574 | 2,859 | N/A |
| 3/31/2020 | 4,826 | 889 | 1,230 | 1,684 | N/A |
| 12/31/2019 | 4,636 | 753 | 174 | 614 | N/A |
| 9/30/2019 | 4,559 | 812 | 128 | 559 | N/A |
| 6/30/2019 | 4,462 | 791 | 219 | 732 | N/A |
| 3/31/2019 | 4,343 | 760 | 176 | 653 | N/A |
| 12/31/2018 | 4,183 | 727 | 409 | 798 | N/A |
| 9/30/2018 | 4,029 | 693 | 70 | 525 | N/A |
| 6/30/2018 | 3,903 | 664 | N/A | 374 | N/A |
| 3/31/2018 | 3,681 | 620 | N/A | 265 | N/A |
| 12/31/2017 | 3,542 | 592 | N/A | 242 | N/A |
| 9/30/2017 | 3,333 | 595 | N/A | 355 | N/A |
| 6/30/2017 | 3,073 | 567 | N/A | 455 | N/A |
| 3/31/2017 | 2,808 | 544 | N/A | 463 | N/A |
| 12/31/2016 | 2,640 | 500 | N/A | 674 | N/A |
| 9/30/2016 | 2,470 | 464 | N/A | 657 | N/A |
| 6/30/2016 | 2,440 | 444 | N/A | 632 | N/A |
| 3/31/2016 | 2,295 | 398 | N/A | 659 | N/A |
| 12/31/2015 | 2,104 | 364 | N/A | 543 | N/A |
| 9/30/2015 | 1,951 | 377 | N/A | 440 | N/A |
| 6/30/2015 | 1,838 | 357 | N/A | 338 | N/A |
| 3/31/2015 | 1,754 | 311 | N/A | 272 | N/A |
| 12/31/2014 | 1,682 | 297 | N/A | 206 | N/A |
| 9/30/2014 | 1,658 | 300 | N/A | 144 | N/A |
| 6/30/2014 | 1,614 | 294 | N/A | 123 | N/A |
| 3/31/2014 | 1,526 | 276 | N/A | 139 | N/A |
| 12/31/2013 | 1,424 | 258 | N/A | 124 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei 002223 ( 18.7% per jaar) ligt boven de spaarquote ( 2.8% ).
Winst versus markt: De winst van 002223 ( 18.7% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 25.9% per jaar).
Hoge groeiwinsten: De winst van 002223 zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van 002223 ( 16% per jaar) zal naar verwachting sneller groeien dan de markt CN ( 13.8% per jaar).
Hoge groei-inkomsten: De omzet van 002223 ( 16% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen 002223 zal naar verwachting over 3 jaar laag zijn ( 16 %).